Skip to main content
. 2004 Feb;135(2):209–218. doi: 10.1111/j.1365-2249.2003.02359.x

Fig. 8.

Fig. 8

DC subsets can modulate the development of diabetes in NOD mice. Ability of CD8+ (♦) and CD8 (○) splenic DC to modulate diabetes development in NOD mice. NOD mice (5 weeks of age; 10 mice/group) were given peptide-pulsed DC (4 × 105 DC/mouse iv) as described in the methods and were monitored for the development of diabetes. Control mice received an iv injection of PBS (▪). Results shown are from two independent experiments.